BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jones J, Nguyen H, Drummond K, Morokoff A. Circulating Biomarkers for Glioma: A Review. Neurosurgery 2021;88:E221-30. [PMID: 33442748 DOI: 10.1093/neuros/nyaa540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Eibl RH, Schneemann M. Liquid Biopsy and Primary Brain Tumors. Cancers (Basel) 2021;13:5429. [PMID: 34771592 DOI: 10.3390/cancers13215429] [Reference Citation Analysis]
2 Mathios D, Phallen J. Circulating Biomarkers in Glioblastoma: Ready for Prime Time? Cancer J 2021;27:404-9. [PMID: 34570455 DOI: 10.1097/PPO.0000000000000541] [Reference Citation Analysis]
3 Cocola C, Magnaghi V, Abeni E, Pelucchi P, Martino V, Vilardo L, Piscitelli E, Consiglio A, Grillo G, Mosca E, Gualtierotti R, Mazzaccaro D, La Sala G, Di Pietro C, Palizban M, Liuni S, DePedro G, Morara S, Nano G, Kehler J, Greve B, Noghero A, Marazziti D, Bussolino F, Bellipanni G, D'Agnano I, Götte M, Zucchi I, Reinbold R. Transmembrane Protein TMEM230, a Target of Glioblastoma Therapy. Front Cell Neurosci 2021;15:703431. [PMID: 34867197 DOI: 10.3389/fncel.2021.703431] [Reference Citation Analysis]
4 Bunda S, Zuccato JA, Voisin MR, Wang JZ, Nassiri F, Patil V, Mansouri S, Zadeh G. Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors. Int J Mol Sci 2021;22:4548. [PMID: 33925295 DOI: 10.3390/ijms22094548] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lu W, Chen H, Liang B, Ou C, Zhang M, Yue Q, Xie J. Integrative Analyses and Verification of the Expression and Prognostic Significance for RCN1 in Glioblastoma Multiforme. Front Mol Biosci 2021;8:736947. [PMID: 34722631 DOI: 10.3389/fmolb.2021.736947] [Reference Citation Analysis]